- Home
- OVID vs RDZN Comparison
OVID vs RDZN Comparison
Compare OVID & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- RDZN
- Stock Information
- Founded
- OVID 2014
- RDZN 2015
- Country
- OVID United States
- RDZN United States
- Employees
- OVID N/A
- RDZN N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- OVID Health Care
- RDZN Finance
- Exchange
- OVID Nasdaq
- RDZN Nasdaq
- Market Cap
- OVID 88.9M
- RDZN 75.2M
- IPO Year
- OVID 2017
- RDZN N/A
- Fundamental
- Price
- OVID $1.27
- RDZN $0.96
- Analyst Decision
- OVID Strong Buy
- RDZN Strong Buy
- Analyst Count
- OVID 4
- RDZN 2
- Target Price
- OVID $3.13
- RDZN $5.00
- AVG Volume (30 Days)
- OVID 1.5M
- RDZN 202.5K
- Earning Date
- OVID 11-11-2025
- RDZN 11-12-2025
- Dividend Yield
- OVID N/A
- RDZN N/A
- EPS Growth
- OVID N/A
- RDZN N/A
- EPS
- OVID N/A
- RDZN N/A
- Revenue
- OVID $6,651,000.00
- RDZN $46,230,126.00
- Revenue This Year
- OVID $708.13
- RDZN $38.45
- Revenue Next Year
- OVID N/A
- RDZN $66.38
- P/E Ratio
- OVID N/A
- RDZN N/A
- Revenue Growth
- OVID 1070.95
- RDZN N/A
- 52 Week Low
- OVID $0.24
- RDZN $0.68
- 52 Week High
- OVID $1.47
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- OVID 55.01
- RDZN 42.76
- Support Level
- OVID N/A
- RDZN $0.93
- Resistance Level
- OVID $1.35
- RDZN $1.00
- Average True Range (ATR)
- OVID 0.10
- RDZN 0.05
- MACD
- OVID -0.07
- RDZN 0.00
- Stochastic Oscillator
- OVID 93.78
- RDZN 46.46
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.